Analyst Group Comment on that Nosa Plugs’ product Odor Control has been procured in Marseille, France
Nosa Plugs AB (“Nosa Plugs” or “the Company”) announced on 17 December 2025 that the Company’s product NOSA Odor Control, a discreet nasal plug designed for use in environments with unpleasant odors, has been procured by the French healthcare region APHM, which covers Provence in France. The procurement targets public healthcare institutions, military hospitals, and certain other actors in the region, including Marseille University Hospital. The agreement immediately comes into force and runs for an initial period of 12 months, with extensions of up to a total of four years.
In summary, the procurement of Odor Control within the French healthcare region APHM represents an important commercial milestone for Nosa Plugs in France. Regional procurements complement the national UGAP framework through more competitive pricing, which is expected to increase adoption within the healthcare sector. Given the product’s recurring use and high customer loyalty, the agreement is assessed to create stable and predictable revenue streams and to serve as a reference for additional regional procurements. Analyst Group therefore views the procurement as a key step in Nosa Plugs’ continued expansion in the French market.
Read Analyst Group’s comment here
About Analyst Group: One of Sweden's leading equity research boutiques with focus on small and medium-sized listed companies.
Read more about Analyst Group
This is a press release from Analyst Group regarding the publication of a comment on Nosa Plugs. Readers may assume that Analyst Group has received compensation for making the comment. The Company has not been given an opportunity to influence the parts where Analyst Group has had opinions about the Company, future valuation or anything else that could be considered a subjective assessment.